1. Home
  2. FBK vs ARQT Comparison

FBK vs ARQT Comparison

Compare FBK & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$55.02

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.19

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBK
ARQT
Founded
1906
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
FBK
ARQT
Price
$55.02
$24.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$62.75
$34.00
AVG Volume (30 Days)
283.7K
1.1M
Earning Date
04-13-2026
05-05-2026
Dividend Yield
1.49%
N/A
EPS Growth
N/A
88.79
EPS
2.45
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$43.54
$34.46
Revenue Next Year
$7.86
$29.77
P/E Ratio
$23.04
N/A
Revenue Growth
N/A
91.34
52 Week Low
$39.47
$12.42
52 Week High
$62.37
$31.77

Technical Indicators

Market Signals
Indicator
FBK
ARQT
Relative Strength Index (RSI) 59.01 52.71
Support Level $51.79 $22.56
Resistance Level $56.30 $25.03
Average True Range (ATR) 1.14 0.96
MACD 0.69 0.35
Stochastic Oscillator 72.98 77.75

Price Performance

Historical Comparison
FBK
ARQT

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: